Pfizer Inc vs Invesco S&P 500 Low Volatility ETF — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while Invesco S&P 500 Low Volatility ETF trades at $76.13. The key difference: Pfizer Inc pays a 6.9% dividend while Invesco S&P 500 Low Volatility ETF pays none, and Invesco S&P 500 Low Volatility ETF is trading nearer its 52-week high, Pfizer Inc nearer its low. Which is the better fit depends on your goals.
| PFE | SPLV | |
|---|---|---|
Market Cap | $142.14B | — |
Volume | 29,869,932 | — |
Sector | Health | — |
52-Week High | $28.56 | $77.45 |
52-Week Low | $23.29 | $70.30 |
Enterprise Value | $192.80B | — |
Dividend Yield | 6.9% | — |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
SPLV trades at $76.09, down 0.63% on the day, with a bullish technical signal driven by moving averages. The ETF focuses on low-volatility S&P 500 stocks, offering stability amid market tensions. Recent news highlights its appeal as a defensive play during geopolitical and inflation concerns. Dividend payments of $0.14 per share are scheduled for mid-2026.
The outlook for SPLV is positive as a defensive equity holding, with low volatility strategies gaining traction in uncertain markets. Key risks include reliance on market volatility for relevance and potential underperformance in strong bull markets. Analyst sentiment is neutral to positive given current macroeconomic conditions.
Trailing returns across standard periods
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →